anti-oestrogenic

(redirected from anti-estrogenic)

anti-oestrogenic

adjective Referring to an effect that suppresses or inhibits oestrogenic activity.
 
noun An agent that counters oestrogenic activity.
Mentioned in ?
References in periodicals archive ?
amp;nbsp;In 2016, before UFC he was tested positive for anti-estrogenic agents.
Smoking was confirmed to be strongly associated with persistent hot flashes, due to tobacco's well-researched anti-estrogenic effects.
This finding suggests that 3-MC exerts a strong anti-estrogenic effect by downregulating ER[alpha] expression.
Phytoestrogens, structurally not identical to human hormones, have mixed estrogenic and anti-estrogenic effects, which depend on the tissue.
The beneficial side effects due to its anti-estrogenic effect on the breast and mild agonistic effect on bone, vagina and serum lipids make Ormeloxifene more preferable for treatment of menorrhagia.
Tamoxifen belongs to selective estrogen receptor modulators (SERMs) class of drugs, which is having both estrogenic and anti-estrogenic effects.
Regarding agents with anti-estrogenic activity the only data currently available date back to 2006 and the same discussion can be done for narcotics for which there are data only for the years 2009 and 2010, respectively, with a consumption of 3.
Many breast cancer patients are prescribed tamoxifen as adjuvant therapy, but the anti-estrogenic effects of tamoxifen may not prevent pregnancy (Cancer Imaging 2008;8:135-45).
The parent compound 1- bis(3'-indolyl)methane is derived from indole-3- carbinol and exhibits estrogenic anti-estrogenic anti- androgenic and Ah receptor agonist activity [1 2].
Vegetables such as broccoli, cabbage, cauliflower, kale and Brussels sprouts have a natural compound Indole 3-carbinole (I3C) - which occurs when the vegetables are chopped or eaten - and this has anti-estrogenic properties that can protect against cervical cancer.
Seventy percent of breast cancers are estrogen receptor (ER)-positive, and are therefore presumed to be hormone-responsive and potentially treatable or preventable by anti-estrogenic agents.
Ligands like tamoxifen and raloxifen are anti-estrogenic but tamoxifen resistant breast cancers lead to speculation about hormone-independent activation pathways of ER and possible ER mutants.